Phase 3 Readout
INTS: Phase 3 Topline: A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Adminis
December 1, 2028. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 1, 2028
- Company
- INTENSITY THERAPEUTICS, INC. (INTS)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Adminis
- Indication
- Sarcoma,Soft Tissue